Literature DB >> 28286434

Review.

Maureen M Jonas1, Christine Lee1.   

Abstract

Year:  2006        PMID： 28286434      PMCID： PMC5335631     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Cytokines in alcoholic liver disease.

Authors:  C J McClain; S Barve; I Deaciuc; M Kugelmas; D Hill
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

Review 2.  Hepatic overlap syndromes.

Authors:  Ulrich Beuers
Journal:  J Hepatol       Date:  2004-12-13       Impact factor: 25.083

3.  Infliximab-associated reversible cholestatic liver disease.

Authors:  V V Menghini; A S Arora
Journal:  Mayo Clin Proc       Date:  2001-01       Impact factor: 7.616

4.  Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

Authors:  Herbert Tilg; Rajiv Jalan; Arthur Kaser; Nathan A Davies; Felix A Offner; Stephen J Hodges; Othmar Ludwiczek; Deborah Shawcross; Heinz Zoller; Akeel Alisa; Rajeshwar P Mookerjee; Ivo Graziadei; Christian Datz; Michael Trauner; Detlef Schuppan; Peter Obrist; Wolfgang Vogel; Roger Williams
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

5.  Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

Authors:  R P Mookerjee; S Sen; N A Davies; S J Hodges; R Williams; R Jalan
Journal:  Gut       Date:  2003-08       Impact factor: 23.059
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.